Pacer Advisors, Inc. Agenus Inc Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$2.56 - $5.49 $39,050 - $83,744	-15,254 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$2.69 - $5.25 $624 - $1,218	-232 Reduced 1.5%	15,254 $41,000
Q4 2020 Jan 20, 2021	BUY	$3.17 - $4.49 $25,119 - $35,578	7,924 Added 104.79%	15,486 $49,000
Q3 2020 Oct 19, 2020	BUY	$2.98 - $5.2 $22,534 - $39,322	7,562 New	7,562 $30,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.